Peptides Are Exploding. Payments Isn’t Ready
Peptides Are Exploding. Payments Isn’t Ready. The Research-Peptide Market Is Growing Faster Than the Infrastructure Built to Underwrit...
A bipartisan coalition of 39 state and territory attorneys general has called on Congress to eliminate the legal pathway that enabled the intoxicating hemp product market. The coalition delivered a letter to key appropriations and agriculture committee leaders requesting federal clarification that would effectively shut down the multi-billion dollar hemp-derived THC industry.
The 2018 Farm Bill created an exception that manufacturers have used to produce intoxicating hemp products. The attorneys general argue this exception represents an unintended loophole that Congress must close. Their letter urges lawmakers to clarify that intoxicating hemp THC products of any kind and derivation are unlawful under federal law.
The coalition submitted its request through the National Association of Attorneys General. The letter targets language in the FY26 Agriculture Appropriations Bill. Section 759 of the House version proposes significantly narrowing hemp's statutory definition. The House and Senate have split over hemp provisions, with conference negotiations currently underway.
The attorneys general focus specifically on manufacturing processes that convert hemp-derived CBD into potent THC isomers and analogs. Products containing delta-8 THC, delta-10 THC, HHC, and THC-O have proliferated nationwide. Manufacturers market these products in formats that officials claim appeal to youth consumers.
The coalition cites reported increases in poison control exposures linked to intoxicating hemp products. They argue the current patchwork of state regulations cannot adequately address interstate commerce and mail-order distribution. Federal intervention appears necessary to establish consistent age restrictions, labeling requirements, and safety standards.
The letter gives minimal acknowledgment to existing state regulatory systems governing intoxicating hemp products. Dozens of states have implemented comprehensive frameworks that include age restrictions, mandatory product testing, packaging and labeling standards, and potency limits. Many states have explicitly banned synthetically-derived cannabinoids including certain THC variants.
Several attorneys general who signed the coalition letter represent states with established hemp regulation programs. These frameworks have created thriving regulated markets with clear compliance requirements. Hemp industry stakeholders note this contradiction between requesting federal action while operating functional state-level regulatory systems.
The prolonged government shutdown has stalled the Agriculture Appropriations Bill. However, the coalition letter signals that pressure for federal hemp restrictions continues building regardless of immediate legislative movement. The hemp industry must prepare for potential regulatory changes that could fundamentally reshape market access and product portfolios.
Maintain Compliance Through Regulatory Uncertainty with Q-Trust
Qredible's Q-Trust quality management system helps hemp and CBD companies navigate complex regulatory requirements across multiple jurisdictions. Our platform provides real-time compliance monitoring, automated alerts for regulatory changes, and comprehensive documentation systems that demonstrate your commitment to safety and transparency. Contact our team to learn how Q-Trust protects your business through periods of regulatory uncertainty.
